HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria A Simonova Selected Research

glucosaminylmuramyl- 2- alanine- D- isoglutamine

4/2010GMDP augments antitumor action of the CP/TNFalpha combination in vivo.
9/2006Muramyl peptides augment cytotoxic effect of tumor necrosis factor-alpha in combination with cytotoxic drugs on tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria A Simonova Research Topics

Disease

2Septic Shock (Toxic Shock Syndrome)
10/2014 - 07/2012
2Neoplasms (Cancer)
04/2010 - 09/2006
1COVID-19
06/2021
1Hypersensitivity (Allergy)
05/2018
1Carcinoma (Carcinomatosis)
04/2010
1Melanoma (Melanoma, Malignant)
04/2010
1Ascites
04/2010
1Fibrosarcoma
09/2006
1Breast Neoplasms (Breast Cancer)
09/2006
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2006

Drug/Important Bio-Agent (IBA)

2Enterotoxins (Enterotoxin)IBA
10/2014 - 07/2012
2Cisplatin (Platino)FDA LinkGeneric
04/2010 - 09/2006
2glucosaminylmuramyl- 2- alanine- D- isoglutamineIBA
04/2010 - 09/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2010 - 09/2006
1Secretory Immunoglobulin A (SIgA)IBA
06/2021
1EpitopesIBA
06/2021
1Proteins (Proteins, Gene)FDA Link
06/2021
1Immunoglobulins (Immunoglobulin)IBA
06/2021
1Immunoglobulin E (IgE)IBA
05/2018
1Pharmaceutical PreparationsIBA
04/2010
1Peptides (Polypeptides)IBA
09/2006

Therapy/Procedure

1Drug Therapy (Chemotherapy)
04/2010